VR Logo

Glenmark Pharmaceuticals Ltd. download report


Healthcare | Drugs & Pharma

Glenmark Pharmaceuticals Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2020 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2019 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2018 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2017 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2016 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2015 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2014 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2013 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2012 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2011 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2010 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2009 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2008 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2007 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2006 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2005 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2004 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2003 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2002 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2001 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes
2000 Glenmark Pharmaceuticals Ltd. Annual Report Glenmark Pharmaceuticals Ltd. chairman speech Glenmark Pharmaceuticals Ltd. director's report Glenmark Pharmaceuticals Ltd. management discussion Glenmark Pharmaceuticals Ltd. corporate governance Glenmark Pharmaceuticals Ltd. auditor's report Glenmark Pharmaceuticals Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1977

Chairman: Glenn Saldanha

Managing Director: Glenn Saldanha

Group: Glenmark

Listing: BSE: 532296, NSE: GLENMARK

Country: India

Headquarters: Mumbai, Maharashtra

Website: www.glenmarkpharma.com

Key Facts

Market cap: ₹10,493.83 Cr

Revenue (TTM): ₹12,304.90 Cr

Earnings (TTM): ₹941.68 Cr

Cash: ₹1,411.52 Cr

Total Debt: ₹4,687.43 Cr

Promoters' ownership: 46.65%

Liquidity: High

52 Week range: ₹348.50 - 597.90

Face value: ₹1.00

Shares outstanding: 28,21,68,156

10 Years Aggregate:

  • CFO: ₹9,285.85 Cr
  • EBITDA: ₹14,492.22 Cr
  • Net Profit: ₹7,174.39 Cr

Stock Performance

Time Period Glenmark Pharma. S&P BSE Healthcare S&P BSE Mid Cap
YTD-29.69-11.26-1.66
1 month-4.825.348.60
3 months-9.531.476.17
1 Year-37.70-11.825.82
3 Years-3.5622.7622.04
5 Years-11.6110.869.50
10 Years-1.1212.2714.89
As on 08-Aug-2022
Year Glenmark Pharma. S&P BSE Mid Cap S&P BSE Healthcare
20215.1639.1820.87
202042.7519.8761.45
2019-49.80-3.05-3.55
201816.26-13.31-5.89
2017-33.0648.130.49
2016-3.827.97-12.88
201518.887.4315.06